Gilteritinib In AML Treatment
John Burke, MD, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, discusses Gilteritinib In AML Treatment. At The 60th ASH Annu...
Author: obr
Added: 01/15/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts